Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$137K Sell
1,468
-809
-36% -$71.6K 0.09% 171
2025
Q4
$183K Sell
2,277
-644
-22% -$53.9K 0.1% 259
2025
Q3
$285K Sell
2,921
-1,206
-29% -$97.1K 0.16% 95
2025
Q2
$288K Buy
4,127
+961
+30% +$54.8K 0.17% 72
2025
Q1
$158K Buy
3,166
+1,195
+61% +$75.6K 0.11% 232
2024
Q4
$138K Buy
1,971
+470
+31% +$39K 0.09% 325
2024
Q3
$158K Sell
1,501
-794
-35% -$92.9K 0.1% 272
2024
Q2
$326K Buy
2,295
+744
+48% +$85.8K 0.21% 49
2024
Q1
$173K Buy
1,551
+407
+36% +$48.5K 0.11% 214
2023
Q4
$148K Buy
1,144
+52
+5% +$7.17K 0.1% 266
2023
Q3
$178K Sell
1,092
-403
-27% -$70.9K 0.13% 146
2023
Q2
$274K Buy
1,495
+1,156
+341% +$166K 0.21% 54
2023
Q1
$45K Sell
339
-265
-44% -$31.1K 0.04% 742
2022
Q4
$48K Sell
604
-16
-3% -$1.13K 0.04% 736
2022
Q3
$38K Sell
620
-2
-0.3% -$129 0.03% 796
2022
Q2
$34K Sell
622
-33
-5% -$1.91K 0.03% 843
2022
Q1
$50K Sell
655
-98
-13% -$6.69K 0.03% 799
2021
Q4
$56K Buy
+753
New +$44.6K 0.08% 469

Other funds holding ACLS

Covestor's ACLS Position: Q1 2026 in Review

Covestor reduced its Axcelis (ACLS) stake by 36% in Q1 2026, selling an estimated $71.6K and leaving 1,468 shares worth $137K. The position accounts for 0.09% of the portfolio, ranked #171.

Covestor first reported a position in ACLS in Q4 2021 and has held it in 18 quarters since. The position peaked at $326K in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Covestor held 1,468 shares of Axcelis worth $137K as of Q1 2026.
  • Covestor sold 809 Axcelis shares in Q1 2026, an estimated $71.6K.
  • Axcelis made up 0.09% of Covestor's portfolio in Q1 2026, its #171 holding.
  • Covestor first reported a position in Axcelis in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Axcelis position peaked at $326K in Q2 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.